Evidence-based clinical practice guidelines for Liver Cirrhosis 2020

H Yoshiji, S Nagoshi, T Akahane, Y Asaoka… - Journal of …, 2021 - Springer
The first edition of the clinical practice guidelines for liver cirrhosis was published in 2010,
and the second edition was published in 2015 by the Japanese Society of Gastroenterology …

What are the benefits of a sustained virologic response to direct-acting antiviral therapy for hepatitis C virus infection?

GN Ioannou, JJ Feld - Gastroenterology, 2019 - Elsevier
Direct-acting antiviral (DAA) regimens are safe and effective at eradicating hepatitis C virus
(HCV) infection. Unfortunately, DAAs remain expensive, so treatment of all HCV-infected …

EASL recommendations on treatment of hepatitis C: final update of the series☆

JM Pawlotsky, F Negro, A Aghemo, M Berenguer… - Journal of …, 2020 - Elsevier
Hepatitis C virus (HCV) infection is a major cause of chronic liver disease, with
approximately 71 million chronically infected individuals worldwide. Clinical care for patients …

EASL recommendations on treatment of hepatitis C 2018

JM Pawlotsky, F Negro, A Aghemo, M Berenguer… - Journal of …, 2018 - Elsevier
Hepatitis C virus (HCV) infection is a major cause of chronic liver disease, with
approximately 71 million chronically infected individuals worldwide. Clinical care for patients …

Non-invasive prediction of liver-related events in patients with HCV-associated compensated advanced chronic liver disease after oral antivirals

M Pons, S Rodríguez-Tajes, JI Esteban, Z Mariño… - Journal of …, 2020 - Elsevier
Background & Aims It is important to know which patients with hepatitis C are likely to
develop liver-related complications after achieving a sustained virological response (SVR) …

Risk factors for HCC in contemporary cohorts of patients with cirrhosis

F Kanwal, S Khaderi, AG Singal, JA Marrero, N Loo… - Hepatology, 2023 - journals.lww.com
Conclusions: HCC incidence among patients with cirrhosis was lower than previously
reported. HCC risk was variable across etiologies, with higher risk in patients with HCV …

The changing epidemiology of primary liver cancer

JL Petrick, KA McGlynn - Current epidemiology reports, 2019 - Springer
Abstract Purpose of Review In prior decades, liver cancer was viewed as a neoplasm that
almost exclusively arose among high-risk populations in low-and middle-income countries …

Hepatitis C elimination: opportunities and challenges in 2023

G Taha, L Ezra, N Abu-Freha - Viruses, 2023 - mdpi.com
Hepatitis C Virus (HCV) infection is a leading etiology of liver cirrhosis and its associated
complications, namely, decompensated cirrhosis. As such, hepatitis C potentially …

Hepatocellular carcinoma mechanisms associated with chronic HCV infection and the impact of direct-acting antiviral treatment

S Dash, Y Aydin, KE Widmer… - Journal of hepatocellular …, 2020 - Taylor & Francis
Hepatitis C virus (HCV) infection is the major risk factor for liver cirrhosis and hepatocellular
carcinoma (HCC). The mechanisms of HCC initiation, growth, and metastasis appear to be …

[HTML][HTML] Liver transplantation for hepatocellular carcinoma: management after the transplant

EC Verna, YA Patel, A Aggarwal, AP Desai… - American Journal of …, 2020 - Elsevier
Hepatocellular carcinoma (HCC) is an increasingly common indication for liver
transplantation (LT) in the United States and in many parts of the world. In the last decade …